annual CFF:
-$11.74B+$2.54B(+17.81%)Summary
- As of today (August 24, 2025), NVS annual cash flow from financing activities is -$11.74 billion, with the most recent change of +$2.54 billion (+17.81%) on December 31, 2024.
- During the last 3 years, NVS annual CFF has risen by +$4.53 billion (+27.84%).
- NVS annual CFF is now -387.43% below its all-time high of $4.08 billion, reached on December 31, 2010.
Performance
NVS Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$5.35B+$3.19B(+37.37%)Summary
- As of today (August 24, 2025), NVS quarterly cash flow from financing activities is -$5.35 billion, with the most recent change of +$3.19 billion (+37.37%) on June 30, 2025.
- Over the past year, NVS quarterly CFF has dropped by -$2.15 billion (-67.31%).
- NVS quarterly CFF is now -175.26% below its all-time high of $7.11 billion, reached on September 30, 2010.
Performance
NVS quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$17.28B-$2.15B(-14.24%)Summary
- As of today (August 24, 2025), NVS TTM cash flow from financing activities is -$17.28 billion, with the most recent change of -$2.15 billion (-14.24%) on June 30, 2025.
- Over the past year, NVS TTM CFF has dropped by -$7.48 billion (-76.27%).
- NVS TTM CFF is now -317.79% below its all-time high of $7.93 billion, reached on September 30, 2010.
Performance
NVS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
NVS Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.8% | -67.3% | -76.3% |
| 3 y3 years | +27.8% | -132.6% | -4.0% |
| 5 y5 years | +13.9% | -145.0% | -239.6% |
NVS Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.9% | -1301.5% | +42.0% | -84.8% | +19.9% |
| 5 y | 5-year | -431.5% | +42.9% | -381.8% | +43.8% | -3537.8% | +19.9% |
| alltime | all time | -387.4% | +42.9% | -175.3% | +44.7% | -317.8% | +19.9% |
NVS Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$5.35B(-37.4%) | -$17.28B(+14.2%) |
| Mar 2025 | - | -$8.55B(+185.3%) | -$15.13B(+28.8%) |
| Dec 2024 | -$11.74B(-17.8%) | -$3.00B(+684.3%) | -$11.74B(+25.5%) |
| Sep 2024 | - | -$382.00M(-88.1%) | -$9.35B(-4.6%) |
| Jun 2024 | - | -$3.20B(-38.0%) | -$9.80B(-4.2%) |
| Mar 2024 | - | -$5.16B(+750.7%) | -$10.23B(-28.4%) |
| Dec 2023 | -$14.28B(-30.6%) | -$607.00M(-27.0%) | -$14.29B(-19.2%) |
| Sep 2023 | - | -$832.00M(-77.1%) | -$17.68B(-18.1%) |
| Jun 2023 | - | -$3.63B(-60.7%) | -$21.58B(+6.5%) |
| Mar 2023 | - | -$9.22B(+130.9%) | -$20.26B(-1.5%) |
| Dec 2022 | -$20.56B(+26.4%) | -$3.99B(-15.7%) | -$20.56B(+3.7%) |
| Sep 2022 | - | -$4.74B(+105.8%) | -$19.82B(+19.3%) |
| Jun 2022 | - | -$2.30B(-75.8%) | -$16.61B(-3.7%) |
| Mar 2022 | - | -$9.53B(+193.1%) | -$17.25B(+6.1%) |
| Dec 2021 | -$16.26B(+636.6%) | -$3.25B(+111.9%) | -$16.26B(+2.0%) |
| Sep 2021 | - | -$1.53B(-47.8%) | -$15.95B(+27.4%) |
| Jun 2021 | - | -$2.94B(-65.6%) | -$12.52B(+6.4%) |
| Mar 2021 | - | -$8.54B(+190.9%) | -$11.76B(+432.7%) |
| Dec 2020 | -$2.21B(-83.8%) | -$2.94B(-254.5%) | -$2.21B(+364.8%) |
| Sep 2020 | - | $1.90B(-187.0%) | -$475.00M(-90.7%) |
| Jun 2020 | - | -$2.19B(-315.7%) | -$5.09B(+73.6%) |
| Mar 2020 | - | $1.01B(-184.2%) | -$2.93B(-78.5%) |
| Dec 2019 | -$13.63B(+221.1%) | -$1.20B(-55.7%) | -$13.63B(+13.8%) |
| Sep 2019 | - | -$2.71B(+9589.3%) | -$11.97B(+10.0%) |
| Jun 2019 | - | -$28.00M(-99.7%) | -$10.88B(-12.1%) |
| Mar 2019 | - | -$9.68B(-2237.5%) | -$12.38B(+191.7%) |
| Dec 2018 | -$4.24B(-45.1%) | $453.00M(-127.9%) | -$4.24B(-40.2%) |
| Sep 2018 | - | -$1.62B(+5.9%) | -$7.09B(-4.3%) |
| Jun 2018 | - | -$1.53B(-1.0%) | -$7.41B(-16.7%) |
| Mar 2018 | - | -$1.55B(-35.5%) | -$8.89B(+15.0%) |
| Dec 2017 | -$7.73B(+45.5%) | -$2.40B(+23.7%) | -$7.73B(+1.2%) |
| Sep 2017 | - | -$1.94B(-35.7%) | -$7.64B(+26.4%) |
| Jun 2017 | - | -$3.01B(+676.3%) | -$6.04B(+29.3%) |
| Mar 2017 | - | -$388.00M(-83.2%) | -$4.67B(-12.0%) |
| Dec 2016 | -$5.31B(-42.1%) | -$2.30B(+573.4%) | -$5.31B(-8.2%) |
| Sep 2016 | - | -$342.00M(-79.2%) | -$5.79B(-24.3%) |
| Jun 2016 | - | -$1.64B(+59.9%) | -$7.64B(-9.6%) |
| Mar 2016 | - | -$1.03B(-63.0%) | -$8.45B(-7.9%) |
| Dec 2015 | -$9.18B(+12.6%) | -$2.77B(+26.4%) | -$9.18B(+28.5%) |
| Sep 2015 | - | -$2.20B(-10.4%) | -$7.14B(+20.7%) |
| Jun 2015 | - | -$2.45B(+39.6%) | -$5.92B(-3.3%) |
| Mar 2015 | - | -$1.75B(+136.5%) | -$6.12B(-24.9%) |
| Dec 2014 | -$8.15B(-7.1%) | -$742.00M(-23.8%) | -$8.15B(-8.7%) |
| Sep 2014 | - | -$973.25M(-63.3%) | -$8.92B(-4.5%) |
| Jun 2014 | - | -$2.65B(-29.9%) | -$9.34B(+1.6%) |
| Mar 2014 | - | -$3.78B(+149.1%) | -$9.19B(+4.8%) |
| Dec 2013 | -$8.77B | -$1.52B(+9.1%) | -$8.77B(+3.5%) |
| Sep 2013 | - | -$1.39B(-44.4%) | -$8.47B(-8.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2013 | - | -$2.50B(-25.5%) | -$9.25B(+10.4%) |
| Mar 2013 | - | -$3.36B(+175.2%) | -$8.38B(+25.6%) |
| Dec 2012 | -$6.67B(-55.1%) | -$1.22B(-43.8%) | -$6.68B(-29.5%) |
| Sep 2012 | - | -$2.17B(+32.7%) | -$9.46B(-12.9%) |
| Jun 2012 | - | -$1.63B(-1.0%) | -$10.86B(-32.1%) |
| Mar 2012 | - | -$1.65B(-58.8%) | -$16.00B(+7.6%) |
| Dec 2011 | -$14.87B(-464.2%) | -$4.01B(+12.3%) | -$14.87B(+0.2%) |
| Sep 2011 | - | -$3.57B(-47.3%) | -$14.84B(+256.9%) |
| Jun 2011 | - | -$6.77B(+1210.9%) | -$4.16B(-217.3%) |
| Mar 2011 | - | -$516.72M(-87.0%) | $3.54B(-13.2%) |
| Dec 2010 | $4.08B(+45.9%) | -$3.98B(-156.0%) | $4.08B(-48.5%) |
| Sep 2010 | - | $7.11B(+666.4%) | $7.93B(+538.7%) |
| Jun 2010 | - | $928.28M(+4119.8%) | $1.24B(-47.5%) |
| Mar 2010 | - | $22.00M(-116.9%) | $2.37B(-15.4%) |
| Dec 2009 | $2.80B(-208.7%) | -$130.05M(-130.8%) | $2.80B(-446.7%) |
| Sep 2009 | - | $422.02M(-79.5%) | -$807.07M(+46.6%) |
| Jun 2009 | - | $2.05B(+354.4%) | -$550.51M(-137.7%) |
| Mar 2009 | - | $452.03M(-112.1%) | $1.46B(-156.8%) |
| Dec 2008 | -$2.57B(-72.4%) | -$3.74B(-650.4%) | -$2.57B(-321.4%) |
| Sep 2008 | - | $678.58M(-83.3%) | $1.16B(-148.3%) |
| Jun 2008 | - | $4.07B(-213.5%) | -$2.41B(-67.0%) |
| Mar 2008 | - | -$3.58B(+24.0%) | -$7.28B(+18.1%) |
| Dec 2007 | -$9.32B(+89.0%) | - | - |
| Sep 2007 | - | -$2.89B(+258.1%) | -$6.16B(+64.7%) |
| Jun 2007 | - | -$806.60M(-67.3%) | -$3.74B(+0.5%) |
| Mar 2007 | - | -$2.47B(+427.1%) | -$3.72B(+206.3%) |
| Dec 2006 | -$4.93B(+1726.3%) | - | - |
| Sep 2006 | - | -$467.93M(-40.6%) | -$1.22B(-8.5%) |
| Jun 2006 | - | -$787.79M(-55.0%) | -$1.33B(-382.7%) |
| Mar 2006 | - | -$1.75B(-197.7%) | $469.87M(-263.8%) |
| Dec 2005 | -$270.00M(-90.9%) | $1.79B(-408.0%) | -$286.93M(-75.6%) |
| Sep 2005 | - | -$581.05M(-157.5%) | -$1.18B(-20.7%) |
| Jun 2005 | - | $1.01B(-140.3%) | -$1.48B(-52.7%) |
| Mar 2005 | - | -$2.51B(-378.5%) | -$3.13B(+5.2%) |
| Dec 2004 | -$2.98B(-47.9%) | $899.59M(-201.3%) | -$2.98B(-23.2%) |
| Sep 2004 | - | -$887.67M(+38.7%) | -$3.88B(+29.7%) |
| Jun 2004 | - | -$639.95M(-72.8%) | -$2.99B(+27.2%) |
| Mar 2004 | - | -$2.35B(-363.7%) | -$2.35B(-363.7%) |
| Dec 2003 | -$5.72B(+34.5%) | - | - |
| Dec 2002 | -$4.25B(+1928.7%) | $892.11M | $892.11M |
| Dec 2001 | -$209.66M(-92.5%) | - | - |
| Dec 2000 | -$2.81B(-2.0%) | - | - |
| Dec 1999 | -$2.87B(-33.5%) | - | - |
| Dec 1998 | -$4.32B(+140.0%) | - | - |
| Dec 1997 | -$1.80B(+26.9%) | - | - |
| Dec 1996 | -$1.42B(+4831.3%) | - | - |
| Dec 1995 | -$28.79M(-101.8%) | - | - |
| Dec 1994 | $1.57B(+173.6%) | - | - |
| Dec 1993 | $573.85M | - | - |
FAQ
- What is Novartis AG annual cash flow from financing activities?
- What is the all time high annual CFF for Novartis AG?
- What is Novartis AG annual CFF year-on-year change?
- What is Novartis AG quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Novartis AG?
- What is Novartis AG quarterly CFF year-on-year change?
- What is Novartis AG TTM cash flow from financing activities?
- What is the all time high TTM CFF for Novartis AG?
- What is Novartis AG TTM CFF year-on-year change?
What is Novartis AG annual cash flow from financing activities?
The current annual CFF of NVS is -$11.74B
What is the all time high annual CFF for Novartis AG?
Novartis AG all-time high annual cash flow from financing activities is $4.08B
What is Novartis AG annual CFF year-on-year change?
Over the past year, NVS annual cash flow from financing activities has changed by +$2.54B (+17.81%)
What is Novartis AG quarterly cash flow from financing activities?
The current quarterly CFF of NVS is -$5.35B
What is the all time high quarterly CFF for Novartis AG?
Novartis AG all-time high quarterly cash flow from financing activities is $7.11B
What is Novartis AG quarterly CFF year-on-year change?
Over the past year, NVS quarterly cash flow from financing activities has changed by -$2.15B (-67.31%)
What is Novartis AG TTM cash flow from financing activities?
The current TTM CFF of NVS is -$17.28B
What is the all time high TTM CFF for Novartis AG?
Novartis AG all-time high TTM cash flow from financing activities is $7.93B
What is Novartis AG TTM CFF year-on-year change?
Over the past year, NVS TTM cash flow from financing activities has changed by -$7.48B (-76.27%)